ESMO 2017: Preparatory Information for Industry

To get up to speed with your preparation for ESMO 2017, please download our Industry Guidelines below.

Other relevant information will be added to this page and don't forget to bookmark us for easy access.

Third-party media activites

Media activities initiated by third parties during or in connection with ESMO 2017, including, but not limited to:

  • Meetings such as press conferences, media briefings, educational sessions for media representatives, as well as
  • PR activities, such as press releases, news, articles, interviews, etc.

are subject to the ESMO 2017 Policy on Third-Party Media Activities. This policy aims to guarantee proper and correct distribution of oncology and cancer-related information to media representatives in connection with the conference.

Press events in or outside the congress centre but concomitant with/or during breaks of the scientific programme of ESMO 2017 are subject to ESMO Press Office approval. Please contact media@esmo.org

Official Italian Agency for AIFA Procedure

Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the event.

ESMO advises pharmaceutical companies to contact the Official Agency:

AIM Group International – AIM Education S.r.l.
Contact: Cristina Ghidoli
Via G. Ripamonti, 129 
20141 Milan, Italy
Tel: +39 02 56601.1
Fax: +39 02-70048585
E-mail:  aifa@aimgroup.eu